PP
FATE icon

PDT Partners’s Fate Therapeutics FATE Stock Holding History

PDT Partners’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-138,814
Closed -$294K – 578
2023
Q3 		$294K Buy
+138,814
New +$460K 0.04% 480
2022
Q3 		– Sell
-20,683
Closed -$513K – 915
2022
Q2 		$513K Buy
+20,683
New +$571K 0.05% 593
2021
Q4 		– Sell
-19,482
Closed -$1.16M – 913
2021
Q3 		$1.16M Buy
+19,482
New +$1.53M 0.08% 317
2021
Q2 		– Sell
-2,667
Closed -$220K – 848
2021
Q1 		$220K Buy
+2,667
New +$256K 0.02% 688
2020
Q4 		– Sell
-8,749
Closed -$350K – 738
2020
Q3 		$350K Buy
+8,749
New +$305K 0.02% 527

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return